AI assistant
Sending…
BioXcel Therapeutics, Inc. — Director's Dealing 2024
Nov 25, 2024
34564_dirs_2024-11-25_5bfd79d1-e285-4914-a68e-2b2614073834.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioXcel Therapeutics, Inc. (BTAI)
CIK: 0001720893
Period of Report: 2024-11-21
Reporting Person: MACK DAVID J. (Director)
More from BioXcel Therapeutics, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 12
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Feb 6
Regulatory Filings
2026
Jan 20